On PharmTech.com this week, coverage of upcoming events continued, experts continued to discuss the use of AI in pharma, and validation in oral solid dosage product production was emphasized.
News|Articles|October 11, 2017
EMA Updates Guidelines on Excipients in Labeling
Author(s)Pharmaceutical Technology Editors
Europe updates the guideline on excipients information in labeling and packaging.
Advertisement
On October 9, 2017, the European Medicines Agency (EMA) announced that the
The guideline was updated to take into consideration safety concerns not currently addressed in the existing annex, with specific attention to excipients that may affect children or pregnant women. Five new excipients are included, and 10 have been updated with new safety warnings.
Source:
Advertisement
Related to this article
This week saw predictive modeling, microstructure intelligence, a CAR T-cell safety pause, and major licensing deals reshape pharma manufacturing.
The finalists for the 2026 CPHI Pharma Awards span 15 categories including API development, digital transformation, manufacturing, supply chain, sustainability, and leadership, with winners revealed October 6 at CPHI Milan.
In August 2026, Heidi Overton was nominated for FDA commission, and a wave of oncology and neuro drugs were approved.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Lori Dingledine, QC Director Microbiological Control and GTIC Operations at Genentech, provided input on the regulations surrounding raw material manufacturing and use for ATMPs in a presentation at the 2026 PDA/FDA Joint Regulatory Conference.
AI can turn medical device risk management into a continuous signal.
Advertisement
Advertisement